指南与共识妇产影像儿科影像US

胎儿超声心动图的指征:基于证据的国家和国际指南间的共识与争议

Indications for fetal echocardiography: consensus and controversies among evidence-based national and international guidelines.
指南 / 共识 · Ultrasound Obstet Gynecol · 2025-04-10

该研究系统检索2008年1月至2023年10月发表的英文指南和专家共识,纳入6份文件,共识别17项胎儿超声心动图指征。完全一致仅3项(17.6%),部分一致8项(47.1%),完全不一致6项(35.3%),争议领域多于共识领域。

要点

  • 完全一致的指征均为胎儿因素:筛查疑似先心病、重大心外畸形、非免疫性水肿。
  • 部分一致的8项包括先心病家族史、颈项透明层增厚、多胎妊娠、母亲糖尿病等。
  • 完全不一致的6项包括遗传病、胎儿遗传学异常、心率和心律异常等。

核心结论

  • 关于哪些先心病风险因素需要胎儿超声心动图的争议领域在数量上多于共识领域,国际标准化共识对医生和指南制定者有价值,许多风险因素需进一步证据支持其作为指征。

研究设计与样本

  • 系统文献检索2008年1月至2023年10月发表的英文胎儿超声心动图指南和专家共识,排除未报告指征者,最终纳入6份文件,列出所有家族性、母体和胎儿风险因素并进行文件间比较。

诊断标准与关键数值

  • 共识别17项胎儿超声心动图指征,完全一致3/17(17.6%),均为胎儿风险因素:筛查疑似先心病、重大胎儿心外畸形、非免疫性水肿。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文结论指出对于许多风险因素,需要进一步证据来证明其作为胎儿超声心动图指征的合理性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Fetal echocardiography (FE) is an indication-driven examination for pregnant women with a fetus at high risk for congenital heart disease (CHD). Several familial, maternal and fetal factors are reported to increase the risk of CHD. The aim of this study was to highlight the existing differences in recommended indications for FE among recently published guidelines and consensuses of experts.

METHODS: Guidelines and expert consensuses published from January 2008 to October 2023 were identified through a systematic literature search. FE guidelines and consensus statements were excluded if not written in the English language and if indications for FE were not reported. All familial, maternal and fetal risk factors for CHD reported in the consensuses and guidelines were listed and comparisons were made between documents. The agreement or disagreement for each risk factor between guidelines and consensuses was classified as: complete agreement (all analyzed documents reported the same indication); partial agreement (all documents considered a risk factor as an indication, but with inconsistency in its definition); or complete disagreement (inconsistency between documents for the considered risk factor as an indication).

RESULTS: Six guidelines and expert consensuses that met the inclusion criteria were identified. Overall, a total of 17 risk factors were identified as an indication for FE. Complete agreement was reached for 3/17 (17.6%) risk factors, all of which are fetal risk factors (suspected CHD at the anomaly scan, presence of major fetal extracardiac abnormality and non-immune hydrops fetalis). Partial agreement was recorded for 8/17 (47.1%) risk factors (family history of CHD, increased nuchal translucency, multiple gestation, maternal diabetes mellitus, maternal phenylketonuria, maternal infection, maternal autoimmune disease and autoantibody positivity, and teratogen exposure). Complete disagreement was recorded for 6/17 (35.3%) risk factors (inherited genetic disease associated with CHD, fetal genetic anomaly, suspected abnormality of heart rate or rhythm, first-trimester sonographic markers of CHD, abnormality of umbilical cord and venous system, and use of assisted reproductive technology).

CONCLUSIONS: Areas of controversy regarding which CHD risk factors warrant FE were greater in quantity than were the areas of consensus. An internationally standardized agreement would be valuable for physicians and guideline developers. For many risk factors, further evidence is needed to justify their use as an indication for FE. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. De Robertis V, Stampalija T, Abuhamad AZ, et al. Indications for fetal echocardiography: consensus and controversies among evidence-based national and international guidelines. Ultrasound Obstet Gynecol. 2025. PMID: 40208627. doi:10.1002/uog.29224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。